Search Results - "Truong, Emily"

Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer by Truong, Emily, Pandol, Stephen, Jeon, Christie

“…Research from epidemiologic studies and experimental animal models provide insights into the role of pancreatic steatosis in the development of pancreatic…”
Get full text

Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017–2018 by Truong, Emily, Yeo, Yee Hui, Cook‐Wiens, Galen, Muthiah, Mark, Yang, Ju Dong, Sundaram, Vinay, Chang, Devon, Todo, Tsuyoshi, Kim, Irene K., Lu, Shelly C., Setiawan, Veronica Wendy, Wong, Vincent W. S., Harrison, Stephen A., Alkhouri, Naim, Noureddin, Mazen

“…Studies have examined nonalcoholic fatty liver disease (NAFLD) prevalence and severity in Asians; however, this is not well understood in Asian Americans (both…”
Get full text

The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease by Truong, Emily, Noureddin, Mazen

“…Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, involving approximately 25% of the general population and…”
Get full text

Reply: Machine learning models for NAFLD/NASH and cirrhosis diagnosis and staging: accuracy and routine variables are the success keys by Chang, Devon, Truong, Emily, Noureddin, Mazen

Get full text

Assessment of the prevalence of non-alcoholic fatty liver disease, its severity, and comorbidities in lean americans: national health and nutrition examination surveys (NHANES) with transient elastography assessment from 2017 to 2018 by Truong, Emily, Cook-Wiens, Galen, Alkhouri, Naim, Noureddin, Mazen

Get full text

MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis by Noureddin, Mazen, Truong, Emily, Gornbein, Jeffrey A., Saouaf, Rola, Guindi, Maha, Todo, Tsuyoshi, Noureddin, Nabil, Yang, Ju Dong, Harrison, Stephen A., Alkhouri, Naim

“…Among the large population of patients with non-alcoholic fatty liver disease (NAFLD), identifying those with fibrotic non-alcoholic steatohepatitis…”
Get full text

Sa1594 MACHINE LEARNING COULD REPLACE SEQUENTIAL TESTING WITH FIB-4 FOLLOWED BY FIBROSCAN® IN THE NAFLD CLINICAL CARE PATHWAY TO DETERMINE THE RISK OF CLINICALLY SIGNIFICANT FIBROSIS IN NAFLD PATIENTS by Chang, Devon, Truong, Emily, Noureddin, Nabil, Mena, Edward A., Alkhouri, Naim, Harrison, Stephen A., Noureddin, Mazen

Get full text

Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis by Aby, Elizabeth, Phan, Jennifer, Truong, Emily, Grotts, Jonathan, Saab, Sammy

“…BACKGROUND:Nonalcoholic steatohepatitis (NASH) is a common cause of liver disease which can progress to cirrhosis and hepatocellular carcinoma (HCC). American…”
Get full text

SAT-408 - Machine learning with routine laboratory tests and clinical features performs similar to current NAFLD clinical pathways by Chang, Devon Y., Truong, Emily, Yang, Ju Dong, Alkhouri, Naim, Harrison, Stephen, Noureddin, Mazen

Get full text

Machine learning with routine laboratory tests and clinical features performs similar to current NAFLD clinical pathways by Chang, Devon Y., Truong, Emily, Yang, Ju Dong, Alkhouri, Naim, Harrison, Stephen, Noureddin, Mazen

Get full text

MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death by Truong, Emily, Gornbein, Jeffrey A., Yang, Ju Dong, Noureddin, Nabil, Harrison, Stephen A., Alkhouri, Naim, Noureddin, Mazen

“…The MRI-AST (MAST) score accurately identifies patients with at-risk nonalcoholic steatohepatitis, defined as nonalcoholic steatohepatitis with nonalcoholic…”
Get full text

Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease by Yelencich, Emily, Truong, Emily, Widaman, Adrianne M., Pignotti, Giselle, Yang, Liu, Jeon, Yejoo, Weber, Andrew T., Shah, Rishabh, Smith, Janelle, Sauk, Jenny S., Limketkai, Berkeley N.

“…Patients with inflammatory bowel disease (IBD) alter their dietary behaviors to reduce disease-related symptoms, avoid feared food triggers, and control…”
Get full text

Improvement in nonalcoholic fatty liver disease through bariatric surgery by Truong, Emily, Noureddin, Mazen

“…Content available: Author Interview and Audio Recording…”
Get full text

Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis by Chang, Devon, Truong, Emily, Mena, Edward A, Pacheco, Fabiana, Wong, Micaela, Guindi, Maha, Todo, Tsuyoshi T, Noureddin, Nabil, Ayoub, Walid, Yang, Ju Dong, Kim, Irene K, Kohli, Anita, Alkhouri, Naim, Harrison, Stephen, Noureddin, Mazen

“…We assessed the performance of machine learning (ML) models in identifying clinically significant NAFLD-associated liver fibrosis and cirrhosis. We implemented…”
Get full text

Impact of COVID-19 Pandemic on Emergency Department Visits for Opioid Use Disorder Across University of California Health Centers by Heshmatipour, Matthew, Ng, Ding Quan, Truong, Emily Yi-Wen, Zheng, Jianwei, Chan, Alexandre, Wang, Yun

“…Introduction: Coronavirus 2019 (COVID-19) has had a devastating impact on mental health and access to addiction treatment in the United States, including in…”
Get full text

Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study by Kim, Beom Kyung, Bergstrom, Jaclyn, Loomba, Rohan, Tamaki, Nobuharu, Izumi, Namiki, Nakajima, Atsushi, Idilman, Ramazan, Gumussoy, Mesut, Oz, Digdem K, Erden, Ayse, Truong, Emily, Yang, Ju Dong, Noureddin, Mazen, Allen, Alina M, Loomba, Rohit, Ajmera, Veeral

“…Magnetic resonance elastography (MRE) is an accurate, continuous biomarker of liver fibrosis; however, the optimal combination with clinical factors to predict…”
Get full text

Excess non-COVID-19-related mortality among inflammatory bowel disease decedents during the COVID-19 pandemic by Rotondo-Trivette, Sarah, He, Xin-Yuan, Samaan, Jamil S, Lv, Fan, Truong, Emily, Juels, Michaela, Nguyen, Anthony, Gao, Xu, Zu, Jian, Yeo, Yee Hui, Ji, Fan-Pu, Melmed, Gil Y

“…The coronavirus disease 2019 (COVID-19) pandemic disrupted healthcare in the United States. To investigate COVID-19-related and non-COVID-19-related death and…”
Get full text

Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease by Truong, Emily, Han, Cheng, Muthiah, Mark, Noureddin, Mazen

“…Purposeof Review This review aims to supply up-to-date recommendations on risk stratification for hepatocellular carcinoma (HCC) in patients with non-alcoholic…”
Get full text

Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF) by Noureddin, Mazen, Truong, Emily, Mayo, Rebeca, Martínez-Arranz, Ibon, Mincholé, Itziar, Banales, Jesus M, Arrese, Marco, Cusi, Kenneth, Arias-Loste, María Teresa, Bruha, Radan, Romero-Gómez, Manuel, Iruzubieta, Paula, Aller, Rocio, Ampuero, Javier, Calleja, José Luis, Ibañez-Samaniego, Luis, Aspichueta, Patricia, Martín-Duce, Antonio, Kushner, Tatyana, Ortiz, Pablo, Harrison, Stephen A, Anstee, Quentin M, Crespo, Javier, Mato, José M, Sanyal, Arun J

“…Early identification of those with NAFLD activity score ≥ 4 and significant fibrosis (≥F2) or at-risk metabolic dysfunction-associated steatohepatitis (MASH)…”
Get full text

Sa1566 NATURAL HISTORY OF HEPATIC DECOMPENSATION AND LIVER-RELATED OUTCOMES IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) by Noureddin, Nabil, Huang, Daniel, Bettencourt, Richele, Siddiqi, Harris, Majzoub, Abdul, Nayfeh, Tarek, Tamaki, Nobuharu, Izumi, Namiki, Nakajima, Atsushi, Idilman, Ramazan, Gumussoy, Mesut, Oz, Digdem Kuru, Erden, Ayse, Truong, Emily, Gidener, Tolga, Allen, Alina M., Noureddin, Mazen, Ajmera, Veeral, Loomba, Rohit

Get full text